Implant-supported overdenture rehabilitation and progressive systemic sclerosis

International Journal of Prosthodontics

Volumn 9, Issue 5, 1996, Pages 440-444

  Raviv, Eli ^a,b   Harel Raviv, Mili ^b,c   Shatz, Peter ^a   Gornitsky, Mervyn ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c McGill University ^*

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CASE REPORT; DENTAL CARE; DENTURE; EDENTULOUSNESS; FEMALE; HUMAN; INSTRUMENTATION; MANDIBLE; METHODOLOGY; SYSTEMIC SCLEROSIS; TOOTH IMPLANTATION; TOOTH PROSTHESIS;

AGED; DENTAL CARE FOR CHRONICALLY ILL; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL PROSTHESIS DESIGN; DENTAL PROSTHESIS, IMPLANT-SUPPORTED; DENTURE, OVERLAY; FEMALE; HUMANS; JAW, EDENTULOUS; MANDIBLE; SCLERODERMA, SYSTEMIC;

EID: 0030228726     PISSN: 08932174     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Rowell NR. Systemic sclerosis. J R Coll Physicians of London 1985;19:23-30.
2. Wood RE, Lee P. Analysis of the oral manifestations of systemic sclerosis (scleroderma). Oral Surg 1989;65:172-178.
3. Marmary Y, Glais R, Pisanty S. Scleroderma: Oral manifestations. Oral Surg 1981;52:32-37.
4. Nunzi E, Neboro A. Are endothelial cells stimulated by autoantibodies in progressive systemic sclerosis? Acta Derm Venereol 1983;63:458-459.
5. Kahaleh MB, Sherer GK, LeRoy EC. Endothelial injury in scleroderma. J Exp Med 1979;149:1326-1335.
6. Langer Y, Cardash HS, Tal H. Use of dental implants in the treatment of patients with scleroderma: A clinical report. J Prosthet Dent 1992;68:873-875.
7. Jensen J, Sindet-Pedersen S. Osseointegrated implants for prosthetic reconstruction in a patient with scleroderma: Report of a case. J Oral Maxillofac Surg 1990;48:739-741.
8. Parel SM. Scleroderma: A prosthetic problem. J Prosthet Dent 1972;27:560-564.
9. Buckingham RB, Prince RK, Rodnan GP, Taylor F. Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis. J Lab Clin Med 1978;92:5-21.
10. Potter SR, Bienenstock J, Goldstein S, Buchanan WW. Fibroblastic growth factors in scleroderma. J Rheumatol 1989;12:1129-1135.
11. Baguley E, Brown KA, Haskard D, Harris EN, Hughes GRV. Antiendothelial cell antibodies in connective tissue diseases. Br J Rheumatol 1987;26:95.
12. Hughes P, Cunningham J, Day M, Fitzgerald JC. Immune complexes in systemic sclerosis. J Clin Lab Immunol 1983;10:133-138.
13. Hughes P, Holt S, Rowell NR, Allonby ID. The relationship of defective cell-mediated immunity to visceral disease in systemic sclerosis. Clin Exp Immunol 1977;28:233-240.